Medidata Solutions Inc. (NASDAQ:MDSO) shares saw strong trading volume on Friday . 284,743 shares changed hands during trading, a decline of 8% from the previous session’s volume of 310,414 shares.The stock last traded at $48.03 and had previously closed at $47.03.

A number of equities research analysts recently weighed in on the company. KeyCorp reissued a “buy” rating on shares of Medidata Solutions in a research report on Thursday. Morgan Stanley reissued a “buy” rating on shares of Medidata Solutions in a research report on Friday, June 10th. Leerink Swann assumed coverage on Medidata Solutions in a research report on Tuesday, April 26th. They set a “market perform” rating and a $47.00 target price on the stock. Jefferies Group downgraded Medidata Solutions from a “hold” rating to an “underperform” rating and lifted their target price for the stock from $35.00 to $36.00 in a research report on Tuesday, April 26th. Finally, Needham & Company LLC restated a “buy” rating and set a $57.00 price target (up previously from $45.00) on shares of Medidata Solutions in a research note on Friday, April 22nd. One analyst has rated the stock with a sell rating, two have issued a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $51.40.

The stock’s 50-day moving average price is $45.71 and its 200-day moving average price is $41.90. The stock has a market capitalization of $2.66 billion and a P/E ratio of 147.76.

Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings results on Thursday, April 21st. The company reported $0.25 EPS for the quarter, beating the Zacks’ consensus estimate of $0.18 by $0.07. The company earned $104.20 million during the quarter, compared to analyst estimates of $103.22 million. During the same quarter last year, the company posted $0.17 EPS. The firm’s quarterly revenue was up 12.7% on a year-over-year basis. On average, equities analysts forecast that Medidata Solutions Inc. will post $1.01 EPS for the current fiscal year.

In related news, President Vries Glen Michael De sold 7,500 shares of the company’s stock in a transaction dated Monday, April 25th. The shares were sold at an average price of $46.36, for a total value of $347,700.00. Following the transaction, the president now owns 1,086,425 shares in the company, valued at approximately $50,366,663. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Eileen Schloss sold 68,717 shares of the company’s stock in a transaction dated Monday, April 25th. The shares were sold at an average price of $46.53, for a total transaction of $3,197,402.01. Following the completion of the transaction, the executive vice president now owns 22,361 shares in the company, valued at approximately $1,040,457.33. The disclosure for this sale can be found here.

Other hedge funds and institutional investors recently made changes to their positions in the company. Sawtooth Asset Management Inc. raised its position in shares of Medidata Solutions by 7,730.8% in the fourth quarter. Sawtooth Asset Management Inc. now owns 20,360 shares of the company’s stock worth $1,004,000 after buying an additional 20,100 shares during the period. Bank of Montreal Can raised its position in shares of Medidata Solutions by 96.6% in the fourth quarter. Bank of Montreal Can now owns 33,760 shares of the company’s stock worth $1,664,000 after buying an additional 16,587 shares during the period. Comerica Bank raised its position in shares of Medidata Solutions by 0.6% in the fourth quarter. Comerica Bank now owns 56,344 shares of the company’s stock worth $2,562,000 after buying an additional 342 shares during the period. Mutual of America Capital Management LLC raised its position in shares of Medidata Solutions by 0.6% in the fourth quarter. Mutual of America Capital Management LLC now owns 57,900 shares of the company’s stock worth $2,854,000 after buying an additional 345 shares during the period. Finally, Rhumbline Advisers raised its position in shares of Medidata Solutions by 9.4% in the fourth quarter. Rhumbline Advisers now owns 68,254 shares of the company’s stock worth $3,364,000 after buying an additional 5,855 shares during the period.

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.